Subretinal Fluid: Causes, Diagnosis and Treatment
What Is Subretinal Fluid
To understand subretinal fluid, it helps to know a little about the layered structure at the back of your eye and how fluid can disrupt it.
The retina is the thin, light-sensitive tissue that lines the inside of the eye and sends visual signals to the brain. Directly beneath the retina sits a single layer of cells called the retinal pigment epithelium (RPE). In a healthy eye, the retina and RPE are closely attached, and no fluid exists between them. When that bond is disrupted, fluid can collect in the potential space between these two layers, creating what is known as subretinal fluid.
Subretinal fluid can originate from several sources. Leaking blood vessels beneath or within the retina may allow plasma or blood to seep into the subretinal space. The RPE itself can become dysfunctional, losing its ability to pump fluid away from the retina efficiently. In other cases, a break or tear in the retina allows vitreous fluid from inside the eye to pass through and settle under the retina.
Even a small amount of subretinal fluid can separate the photoreceptor cells from the RPE, which supplies them with oxygen and nutrients. This separation interferes with normal signal processing and can cause blurred or distorted central vision. If the fluid persists, photoreceptor cells may begin to deteriorate, raising the risk of lasting vision changes. Early detection gives our retina specialists the best opportunity to address the underlying cause before permanent damage occurs.
Conditions That Cause Subretinal Fluid to Accumulate
Many different eye conditions can lead to subretinal fluid. Identifying the specific cause is essential because each condition requires a different treatment approach.
Central serous chorioretinopathy (CSC) is one of the most common causes of subretinal fluid, particularly in adults between the ages of 20 and 50. In CSC, a focal defect in the RPE allows fluid from the choroid, the vascular layer beneath the RPE, to leak into the subretinal space. Stress, corticosteroid use, and type-A personality traits are recognized risk factors. Many episodes of CSC resolve within a few months, but chronic or recurrent cases may require intervention.
In wet (neovascular) age-related macular degeneration (AMD), abnormal blood vessels grow from the choroid through the RPE and into or under the retina. Age-related macular degeneration is the leading cause of irreversible vision loss in adults over 50 in the developed world (World Health Organization). These fragile vessels leak fluid and blood, producing subretinal fluid that can cause rapid central vision loss. Wet AMD is considered a serious, sight-threatening condition that typically requires ongoing treatment with injections to control the leaking vessels.
A retinal detachment occurs when the retina pulls away from the underlying tissue. In a rhegmatogenous detachment, a tear or hole in the retina allows liquid vitreous to flow beneath it, generating subretinal fluid that progressively lifts the retina. Exudative detachments, which occur without a retinal break, can also produce subretinal fluid due to inflammation, tumors, or vascular abnormalities. Retinal detachment is a medical emergency that requires urgent surgical treatment.
Posterior uveitis, Vogt-Koyanagi-Harada (VKH) disease, and posterior scleritis can all cause inflammation that disrupts the RPE barrier and leads to subretinal fluid accumulation. Infectious causes such as toxoplasmosis or syphilis may produce similar findings. Treatment in these cases focuses on controlling the underlying inflammation or infection with medications.
Choroidal tumors, including melanoma and hemangioma, can produce subretinal fluid by compressing surrounding tissue or leaking from abnormal vasculature. Polypoidal choroidal vasculopathy (PCV), a variant of neovascular AMD more common in certain ethnic groups, is another important cause. Optic disc pits, which are congenital structural anomalies, can also allow fluid to track into the subretinal space. Identifying these less common causes often requires specialized imaging and careful clinical evaluation.
Symptoms of Subretinal Fluid
The symptoms you experience depend on how much fluid has accumulated and where it is located relative to the center of the retina.
The most common symptom of subretinal fluid involving the macula is a noticeable drop in the sharpness of your central vision. Straight lines may appear wavy or bent, a phenomenon called metamorphopsia. Reading, recognizing faces, and performing detail-oriented tasks may become more difficult. If the fluid is located outside the macula, you may not notice any symptoms at all until the fluid spreads.
Some patients notice that colors appear washed out or that overall contrast seems reduced in the affected eye. A dim or dark spot in the central visual field can also develop. These changes reflect the disruption of photoreceptor function caused by the fluid separating the retina from its nutrient supply.
In conditions like CSC, symptoms often appear over days and may fluctuate as fluid levels change. In wet AMD or retinal detachment, vision loss can develop more abruptly. A sudden increase in floaters, flashes of light, or a shadow or curtain moving across your field of vision warrants immediate evaluation. Gradual or sudden, any new visual disturbance should prompt a visit to a retina specialist for a thorough examination.
How Subretinal Fluid Is Detected
Our retina specialists rely on several complementary imaging and examination techniques to identify subretinal fluid and determine its cause.
Optical coherence tomography (OCT) is the primary tool for detecting subretinal fluid. This noninvasive scan produces high-resolution cross-sectional images of the retina, allowing our team to visualize even tiny pockets of fluid beneath the neurosensory retina. OCT can also reveal associated findings such as retinal thickening, pigment epithelial detachments, or epiretinal membranes that help narrow the diagnosis. Serial OCT scans are valuable for tracking changes over time and measuring treatment response.
Fluorescein angiography (FA) involves injecting a fluorescent dye into a vein in your arm and photographing the dye as it circulates through the retinal blood vessels. This test highlights areas of leakage, blockage, or abnormal vessel growth that may be responsible for the subretinal fluid. FA is especially helpful in distinguishing between CSC, wet AMD, and other vascular causes.
A comprehensive dilated eye exam allows the retina specialist to directly view the retina, optic nerve, and surrounding structures using specialized lenses and a bright light source. Subretinal fluid may appear as an elevated, dome-shaped area of retina or as a subtle change in the retinal reflex. This clinical evaluation provides important context that guides which additional tests are needed.
Indocyanine green angiography (ICG) uses a different dye that highlights the choroidal vasculature and is particularly useful for diagnosing PCV or chronic CSC. B-scan ultrasonography can assess the eye when the view of the retina is obscured, such as in cases of vitreous hemorrhage. In rare situations, imaging of the orbit or brain may be recommended to evaluate for tumors or other systemic causes of subretinal fluid.
How Subretinal Fluid Is Treated
Treatment is always directed at the underlying cause of the fluid rather than the fluid itself. The goal is to stop the source of leakage so the RPE can pump the fluid away and the retina can reattach to its supporting tissue.
When subretinal fluid results from acute CSC, our retina specialists often recommend a period of careful observation because many cases resolve spontaneously within two to four months. Reducing stress, discontinuing corticosteroid medications when medically safe, and improving sleep habits may support recovery. Regular OCT monitoring during the observation period ensures that the fluid is trending in the right direction.
For subretinal fluid caused by wet AMD or other neovascular conditions, anti-VEGF (vascular endothelial growth factor) medications are the standard of care. These medications are delivered directly into the eye through a brief, well-tolerated office procedure and work by blocking the signals that drive abnormal blood vessel growth and leakage. Most patients require a series of injections, and the treatment schedule is tailored based on how the fluid responds on follow-up OCT scans.
Photodynamic therapy (PDT) uses a light-activated medication to seal leaking areas beneath the retina and is commonly used for chronic CSC or certain subtypes of choroidal neovascularization. Focal laser photocoagulation may also be appropriate in selected cases where the leakage point is well-defined and located away from the center of the macula. These treatments aim to restore RPE integrity and facilitate fluid reabsorption.
When subretinal fluid is caused by a retinal detachment, surgical repair is necessary to reattach the retina and prevent permanent vision loss. Procedures such as pars plana vitrectomy, scleral buckle, or pneumatic retinopexy may be used depending on the type and extent of the detachment. For patients with conditions like a macular hole or optic disc pit contributing to subretinal fluid, vitrectomy surgery can close the defect and allow the fluid to resolve. Tumor-related subretinal fluid may require radiation therapy or other oncologic treatments coordinated with a multidisciplinary team.
Subretinal fluid driven by uveitis, VKH disease, or other inflammatory conditions is typically treated with corticosteroids, immunosuppressive agents, or biologic medications. Controlling the underlying inflammation allows the RPE to regain its normal function and pump the fluid away. Long-term management may be needed to prevent recurrences, and our retina specialists work closely with rheumatologists and other providers when systemic disease is involved.
Frequently Asked Questions
Not always. In some cases, small amounts of subretinal fluid result from self-limiting conditions like acute central serous chorioretinopathy, which often resolves without treatment. However, subretinal fluid can also indicate sight-threatening conditions such as wet AMD or retinal detachment. Because the underlying cause determines the urgency, any new or unexplained fluid should be evaluated promptly by a retina specialist to rule out conditions that require immediate care.
Yes, in certain situations. Acute CSC is the most common example of a condition where subretinal fluid clears on its own, typically within a few months. Mild inflammatory episodes may also produce transient fluid that resolves once the inflammation subsides. Your retina specialist will monitor you with regular OCT scans during the observation period and recommend treatment if the fluid does not improve within an expected timeframe or if vision continues to decline.
Subretinal fluid is a hallmark of wet (neovascular) AMD, where abnormal choroidal blood vessels leak fluid and blood beneath the retina. The presence of new subretinal fluid in a patient with known dry AMD can signal conversion to the wet form, which requires prompt treatment with anti-VEGF injections. Patients with macular edema from other causes may have similar-looking fluid on imaging, so careful diagnosis is important to distinguish between these conditions and guide the correct treatment.
The long-term impact depends on the cause, the amount and duration of fluid accumulation, and how quickly treatment begins. Brief episodes that resolve promptly tend to have a favorable visual outcome, while prolonged or recurrent subretinal fluid can damage photoreceptor cells and lead to lasting central vision changes. Consistent monitoring and timely treatment help preserve the best possible visual function.
After initial diagnosis and treatment, regular follow-up visits that include OCT scanning are the standard approach for tracking subretinal fluid. The frequency of these visits varies depending on the underlying condition. Patients with wet AMD may need monthly or bimonthly monitoring, while those recovering from a single episode of CSC may transition to less frequent check-ups once the fluid has resolved. Home monitoring with an Amsler grid can help you detect new distortion between office visits so you can alert your eye care team right away.
What our Patients say
4.8
Reviews
(3547)